TARO logo

TARO Return On Equity

Annual ROE

3.06%
+1.58%+106.76%

March 31, 2024

Summary

Performance

1-Year Change

+106.76%

3-Year Change

+115.06%

5-Year Change

-77.62%

15-Year Change

-86.56%

TARO ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

49.58%
TARO annual return on equity is currently -93.83% below its historical high of 49.58%

3-Year Low

-20.32%

Earnings dates

Last Annual Earnings Report Date

Mar 31, 2024
TARO previous annual earnings announcement was published on Mar 31, 2024

Next Annual Earnings Report Date

N/A
TARO next annual earnings announcement has not yet been scheduled

OtherTAROprofitabilitymetrics:

Annual Revenue

$629.18 M
TARO annual revenue is $629.18 million

Annual Net Income

$53.87 M
TARO annual net profit is $53.87 million

Annual EPS

$1.43
TARO annual earnings per share is $1.43

Annual ROA

2.51%
TARO annual return on assets is 2.51%

Quarterly ROE

3.06%
+0.43%+16.35%

March 31, 2024

Summary

Performance

3-Month Change

+16.35%

1-Year Change

+16.35%

3-Year Change

+114.17%

5-Year Change

-75.79%

TARO Quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

51.91%
TARO quarterly return on equity is currently -94.11% below its historical high of 51.91%

3-Year Low

0.06%
TARO quarterly return on equity is currently +5000.00% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Mar 31, 2024
TARO previous earnings announcement was published on Mar 31, 2024

Next Quarterly Earnings Report Date

N/A
TARO next earnings announcement has not yet been scheduled

OtherTAROprofitabilitymetrics:

Quarterly Revenue

$164.94 M
TARO quarterly revenue is $164.94 million

Quarterly Net Income

$15.08 M
TARO quarterly net profit is $15.08 million

Quarterly EPS

$0.40
TARO quarterly earnings per share is $0.40

Quarterly ROA

2.51%
TARO quarterly return on assets is 2.51%

ROE Formula

ROE =  Net Income
Shareholders Equity ✕ 100%

Annual ROE

3.06%
TARO annual return on equity is 3.06%

Annual Net Income

$53.87 M
TARO annual net profit is $53.87 million

Annual Shareholders Equity

$1.79 B
TARO annual stockholders equity is $1.79 billion

TARO ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+106.8%+16.4%
3 y3 years+115.1%+114.2%
5 y5 years-77.6%-75.8%

TARO ROE Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-10.5%-764.1%-43.2%-98.0%
5 y5-year-77.6%-764.1%-75.8%-805.9%
alltimeall time-93.8%-3138.6%-94.1%-937.9%

Taro Pharmaceutical Industries ROE History

DateAnnualQuarterly
Mar 2024
3.06%(+106.8%)
3.06%(+16.3%)
Dec 2023
-
2.63%(+38.4%)
Sep 2023
-
1.90%(+53.2%)
Jun 2023
-
1.24%(-16.8%)
Mar 2023
1.48%(-56.7%)
1.49%(-44.6%)
Dec 2022
-
2.69%(-29.6%)
Sep 2022
-
3.82%(-29.1%)
Jun 2022
-
5.39%(+56.2%)
Mar 2022
3.42%(-116.8%)
3.45%(+5650.0%)
Dec 2021
-
0.06%(-86.7%)
Sep 2021
-
0.45%(-74.1%)
Jun 2021
-
1.74%(-108.1%)
Mar 2021
-20.32%(-267.2%)
-21.60%(+33.1%)
Dec 2020
-
-16.23%(+16.3%)
Sep 2020
-
-13.95%(+7.1%)
Jun 2020
-
-13.03%(-207.7%)
Mar 2020
12.15%(-11.1%)
12.10%(-4.3%)
Dec 2019
-
12.64%(-6.9%)
Sep 2019
-
13.57%(+0.1%)
Jun 2019
-
13.55%(+1.9%)
Mar 2019
13.67%(+38.6%)
13.30%(-6.5%)
Dec 2018
-
14.22%(+36.6%)
Sep 2018
-
10.41%(+2.7%)
Jun 2018
-
10.14%(+4.1%)
Mar 2018
9.86%(-56.7%)
9.74%(-0.3%)
Dec 2017
-
9.77%(-38.7%)
Sep 2017
-
15.93%(-20.1%)
Jun 2017
-
19.93%(-13.9%)
Mar 2017
22.76%(-29.4%)
23.16%(-9.4%)
Dec 2016
-
25.56%(-12.8%)
Sep 2016
-
29.32%(-5.9%)
Jun 2016
-
31.17%(-4.6%)
Mar 2016
32.25%(-18.8%)
32.68%(-13.4%)
Dec 2015
-
37.74%(+0.6%)
Sep 2015
-
37.51%(-9.2%)
Jun 2015
-
41.30%(+3.2%)
Mar 2015
39.73%(+5.4%)
40.03%(+6.0%)
Dec 2014
-
37.77%(+1.5%)
Sep 2014
-
37.23%(+7.8%)
Jun 2014
-
34.53%(-7.3%)
Mar 2014
37.71%(+7.2%)
37.23%(+8.6%)
Dec 2013
-
34.27%(+4.7%)
Sep 2013
-
32.72%(+2.9%)
Jun 2013
-
31.80%(-9.0%)
Mar 2013
35.17%(+344.6%)
34.95%(-7.7%)
Dec 2012
-
37.88%(+0.1%)
Sep 2012
-
37.85%(-7.1%)
Jun 2012
-
40.74%(+2.8%)
Mar 2012
7.91%(-79.3%)
39.63%(+1.5%)
Dec 2011
38.23%(+102.9%)
39.06%(+17.9%)
Sep 2011
-
33.12%(+25.0%)
Jun 2011
-
26.50%(+13.7%)
Mar 2011
-
23.31%(+13.6%)
Dec 2010
18.84%(-62.0%)
20.52%(-57.4%)
Sep 2010
-
48.19%(-0.6%)
Jun 2010
-
48.49%(+6.2%)
Mar 2010
-
45.64%(-12.1%)
Dec 2009
49.58%(+157.8%)
51.91%(+240.8%)
Sep 2009
-
15.23%(-17.5%)
Jun 2009
-
18.46%(+17.1%)
Mar 2009
-
15.76%(+278.8%)
Dec 2008
19.23%(-43.2%)
4.16%(-19.7%)
Sep 2008
-
5.18%(+1338.9%)
Dec 2007
33.83%(-136.4%)
-
Dec 2006
-92.98%(<-9900.0%)
-
Dec 2005
0.03%
0.36%(-92.7%)
Sep 2005
-
4.95%(-10.8%)
Jun 2005
-
5.55%(+302.2%)
DateAnnualQuarterly
Mar 2005
-
1.38%(-55.5%)
Dec 2004
3.09%(-84.4%)
3.10%(-53.0%)
Sep 2004
-
6.59%(-35.8%)
Jun 2004
-
10.26%(-42.8%)
Mar 2004
-
17.95%(-9.9%)
Dec 2003
19.75%(+8.5%)
19.92%(-0.4%)
Sep 2003
-
20.00%(+1.7%)
Jun 2003
-
19.66%(+3.3%)
Mar 2003
-
19.03%(+3.3%)
Dec 2002
18.21%(-5.6%)
18.42%(-10.6%)
Sep 2002
-
20.60%(-9.8%)
Jun 2002
-
22.85%(-13.5%)
Mar 2002
-
26.41%(-10.4%)
Dec 2001
19.29%(-12.4%)
29.46%(-19.2%)
Sep 2001
-
36.46%(+18.5%)
Jun 2001
-
30.76%(+25.4%)
Mar 2001
-
24.53%(+9.5%)
Dec 2000
22.02%(+38.3%)
22.40%(+12.2%)
Sep 2000
-
19.96%(+7.0%)
Jun 2000
-
18.65%(+4.0%)
Mar 2000
-
17.93%(+6.3%)
Dec 1999
15.92%(+94.9%)
16.87%(+1.9%)
Sep 1999
-
16.56%(+20.3%)
Jun 1999
-
13.77%(+29.8%)
Mar 1999
-
10.61%(+27.5%)
Dec 1998
8.17%(+57.1%)
8.32%(+75.2%)
Sep 1998
-
4.75%(-7.0%)
Jun 1998
-
5.11%(-7.6%)
Mar 1998
-
5.53%(-0.7%)
Dec 1997
5.20%(-40.3%)
5.57%(-25.9%)
Sep 1997
-
7.52%(+3.2%)
Jun 1997
-
7.29%(-11.2%)
Mar 1997
-
8.21%(-6.3%)
Dec 1996
8.71%(+0.1%)
8.76%(+32.5%)
Sep 1996
-
6.61%(+79.1%)
Jun 1996
-
3.69%(-40.5%)
Mar 1996
-
6.20%(-25.3%)
Dec 1995
8.70%(-49.5%)
8.30%(-39.7%)
Sep 1995
-
13.76%(-18.9%)
Jun 1995
-
16.97%(+5.7%)
Mar 1995
-
16.06%(-30.0%)
Dec 1994
17.22%(+1112.7%)
22.95%(+49.6%)
Sep 1994
-
15.34%(+42.0%)
Jun 1994
-
10.80%(+111.4%)
Mar 1994
-
5.11%(+348.2%)
Dec 1993
1.42%(-87.5%)
1.14%(-112.7%)
Sep 1993
-
-9.00%(+361.5%)
Jun 1993
-
-1.95%(-199.0%)
Mar 1993
-
1.97%(-79.0%)
Dec 1992
11.39%(-48.7%)
9.39%(-46.7%)
Sep 1992
-
17.61%(-15.7%)
Jun 1992
-
20.89%(+32.3%)
Mar 1992
-
15.79%(-29.1%)
Dec 1991
22.22%(-322.2%)
22.28%(-2.5%)
Sep 1991
-
22.86%(+189.7%)
Jun 1991
-
7.89%(-66.9%)
Mar 1991
-
23.81%(-320.3%)
Dec 1990
-10.00%(-10.0%)
-10.81%(-47.3%)
Sep 1990
-
-20.51%(0.0%)
Jun 1990
-
-20.51%(-20.0%)
Mar 1990
-
-25.64%(+169.3%)
Dec 1989
-11.11%(-266.6%)
-9.52%(-242.7%)
Sep 1989
-
6.67%(0.0%)
Jun 1989
-
6.67%(-50.0%)
Mar 1989
-
13.33%(+99.9%)
Dec 1988
6.67%
6.67%(0.0%)
Sep 1988
-
6.67%(0.0%)
Jun 1988
-
6.67%

FAQ

  • What is Taro Pharmaceutical Industries annual return on equity?
  • What is the all time high annual ROE for Taro Pharmaceutical Industries?
  • What is Taro Pharmaceutical Industries annual ROE year-on-year change?
  • What is Taro Pharmaceutical Industries quarterly return on equity?
  • What is the all time high quarterly ROE for Taro Pharmaceutical Industries?
  • What is Taro Pharmaceutical Industries quarterly ROE year-on-year change?

What is Taro Pharmaceutical Industries annual return on equity?

The current annual ROE of TARO is 3.06%

What is the all time high annual ROE for Taro Pharmaceutical Industries?

Taro Pharmaceutical Industries all-time high annual return on equity is 49.58%

What is Taro Pharmaceutical Industries annual ROE year-on-year change?

Over the past year, TARO annual return on equity has changed by +1.58% (+106.76%)

What is Taro Pharmaceutical Industries quarterly return on equity?

The current quarterly ROE of TARO is 3.06%

What is the all time high quarterly ROE for Taro Pharmaceutical Industries?

Taro Pharmaceutical Industries all-time high quarterly return on equity is 51.91%

What is Taro Pharmaceutical Industries quarterly ROE year-on-year change?

Over the past year, TARO quarterly return on equity has changed by +0.43% (+16.35%)